Dr. Delsignore has represented numerous clients in patent matters, including Boehringer Ingelheim, West-Ward Pharmaceuticals International Limited, Concert Pharmaceuticals, Inc., IBM, Hanmi Pharmaceutical Co., Limited, and Teva Pharmaceuticals. Her client work includes:
- Strategies for leveraging federal district court litigation and post patent issue proceedings in the United States Patent and Trademark Office Patent Trial and Appeal Board;
- Freedom to operate strategies related to the launch of FDA approved drugs;
- Evaluation of the intellectual property portfolios of target companies in due diligence studies; and
- Patent procurement and portfolio management for academic institutions.
Dr. Delsignore is a member of the American Intellectual Property Law Association, the PTAB Bar Association, New York Intellectual Property Law Association and New Jersey Intellectual Property Law Association and is a member of the nominating committee for award of the Jefferson Medal. Dr. Delsignore is co-chair of the New York City Bar Association committee on Science and the Law, a member of the New York City Bar Association committee on Drugs and the Law, and chair of the patent subcommittee of the cannabis subcommittee of the American Intellectual Property Law Association.
Prior to joining Goodwin, Dr. Delsignore was head of the Chemical/Pharmaceutical/Biotechnology patent group at Pitney, Hardin Kipp & Szuch, and practiced patent law in the intellectual property group of Baker Botts L.L.P. and in the intellectual property firm of Brumbaugh, Graves, Donohue & Raymond.